Caveolin regulation of endothelial function
- PMID: 14604847
- DOI: 10.1152/ajplung.00242.2003
Caveolin regulation of endothelial function
Abstract
Caveolae are the sites in the cell membrane responsible for concentrating an array of signaling molecules critical for cell function. Recent studies have begun to identify the functions of caveolin-1, the 22-kDa caveolar protein that oligomerizes and inserts into the cytoplasmic face of the plasma membrane. Caveolin-1 appears to regulate caveolar internalization by stabilizing caveolae at the plasma membrane rather than controlling the shape of the membrane invagination. Because caveolin-1 is a scaffolding protein, it has also been hypothesized to function as a "master regulator" of signaling molecules in caveolae. Deletion of the caveolin-1 gene in mice resulted in cardiac hypertrophy and lung fibrosis, indicating its importance in cardiac and lung development. In the endothelium, caveolin-1 regulates nitric oxide signaling by binding to and inhibiting endothelial nitric oxide synthase (eNOS). Increased cytosolic Ca2+ or activation of the kinase Akt leads to eNOS activation and its dissociation from caveolin-1. Caveolae have also been proposed as the vesicle carriers responsible for transcellular transport (transcytosis) in endothelial cells. Transcytosis, the primary means of albumin transport across continuous endothelia, occurs by fission of caveolae from the membrane. This event is regulated by tyrosine phosphorylation of caveolin-1 and dynamin. As Ca2+ influx channels and pumps are localized in caveolae, caveolin-1 is also an important determinant of Ca2+ signaling in endothelial cells. Many of these findings were presented in San Diego, CA, at the 2003 Experimental Biology symposium "Caveolin Regulation of Endothelial Function" and are reviewed in this summary.
Similar articles
-
Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta.J Pharmacol Exp Ther. 2005 Jul;314(1):9-15. doi: 10.1124/jpet.105.083634. Epub 2005 Mar 18. J Pharmacol Exp Ther. 2005. PMID: 15778264
-
Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.Circ Res. 2004 Jul 23;95(2):154-61. doi: 10.1161/01.RES.0000136344.27825.72. Epub 2004 Jun 17. Circ Res. 2004. PMID: 15205364
-
Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities.J Biol Chem. 2001 Oct 12;276(41):38121-38. doi: 10.1074/jbc.M105408200. Epub 2001 Jul 16. J Biol Chem. 2001. PMID: 11457855
-
Caveolae, caveolin and control of vascular tone: nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF) regulation.J Physiol Pharmacol. 2009 Oct;60 Suppl 4:105-9. J Physiol Pharmacol. 2009. PMID: 20083858 Review.
-
Targeting and translocation of endothelial nitric oxide synthase.Braz J Med Biol Res. 1999 Nov;32(11):1361-6. doi: 10.1590/s0100-879x1999001100006. Braz J Med Biol Res. 1999. PMID: 10559837 Review.
Cited by
-
Peroxisome Proliferator-Activated Receptor γ-Mediated Inhibition on Hypoxia-Triggered Store-Operated Calcium Entry. A Caveolin-1-Dependent Mechanism.Am J Respir Cell Mol Biol. 2015 Dec;53(6):882-92. doi: 10.1165/rcmb.2015-0002OC. Am J Respir Cell Mol Biol. 2015. PMID: 26020612 Free PMC article.
-
Depolarization of mitochondria in endothelial cells promotes cerebral artery vasodilation by activation of nitric oxide synthase.Arterioscler Thromb Vasc Biol. 2013 Apr;33(4):752-9. doi: 10.1161/ATVBAHA.112.300560. Epub 2013 Jan 17. Arterioscler Thromb Vasc Biol. 2013. PMID: 23329133 Free PMC article.
-
Role of caveolin-1 expression in the pathogenesis of pulmonary edema in ventilator-induced lung injury.Pulm Circ. 2012 Oct;2(4):452-60. doi: 10.4103/2045-8932.105033. Pulm Circ. 2012. PMID: 23372929 Free PMC article.
-
Size and dynamics of caveolae studied using nanoparticles in living endothelial cells.ACS Nano. 2009 Dec 22;3(12):4110-6. doi: 10.1021/nn9012274. ACS Nano. 2009. PMID: 19919048 Free PMC article.
-
Vascular permeability and drug delivery in cancers.Front Oncol. 2013 Aug 15;3:211. doi: 10.3389/fonc.2013.00211. eCollection 2013. Front Oncol. 2013. PMID: 23967403 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous